Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir
Posted by
www.biotecnika.org
Cipla, Hetero, and Jubilant Lifesciences have signed voluntary
licensing agreements with Gilead.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-hetero-get-nod-to-sell-remdesivir/articleshow/75958389.cms
Subscribe to:
Post Comments (Atom)
Post a Comment